Latest Competition News

Ardiden Limited has completed its merger with Lac Gold, bolstering its position with a $10 million capital raise and launching a significant drilling campaign at the Rouyn Gold Project in Québec.

Experience Co Limited reports a modest half-year revenue increase despite challenges in Q2, driven by strong Reef Unlimited and Skydive New Zealand performances offsetting softness elsewhere.

OM Holdings has recommissioned its Qinzhou manganese smelter in China after a four-year pause due to high power costs, signaling a strategic push to regain production capacity and market share.

Truscott Mining Corporation has initiated a fully subscribed capital raising to fund a 2500-metre drilling program at its Westminster Gold Project, targeting core ore bodies with potential multi-million ounce gold mineralisation.

Orbital Corporation Ltd reports a stronger cash position and a strategic new order for its 350cc heavy fuel engine, signalling growth in both military and commercial UAV markets.

BKI Investment Company reported a solid half-year performance with a 7% rise in operating results and a 1% increase in fully franked dividends, driven by a strategic portfolio rotation favoring resource stocks aligned with global growth themes.

Aeris Environmental Ltd has reported strong commercial momentum with its Syncromesh IoT platform and specialty chemicals, highlighted by initial orders from Budweiser APAC and a growing purchase order pipeline exceeding $800,000.

Avecho Biotechnology is on the cusp of completing patient dosing in its pivotal Phase III CBD insomnia trial, backed by a recent $2.5 million capital raise and patent allowances in the US and Europe.

Neurizon Therapeutics has locked in a $6 million cash rebate from the Australian Government’s R&D Tax Incentive, underpinning its upcoming HEALEY ALS Platform Trial with first patient dosing slated for early 2026.

Platformo Ltd’s Biztrak software arm returned to positive cash flow and profitability in Q4 2025, driven by strategic cost control and digital expansion despite regulatory headwinds in Malaysia.

Anagenics Limited reports a significant turnaround with profitable trading in the second quarter of FY26, driven by strong brand performance and a successful capital raise. The company is poised for growth with expanding product lines and international ambitions.

Elixinol Wellness Ltd reported a 9.5% revenue increase in Q4 FY25 alongside a 30% cut in operating costs, achieving its first underlying operating cash flow positive quarter. The company’s strategic acquisitions and e-commerce growth underpin a clear path to profitability.